Literature DB >> 21593787

Cancer to bone: a fatal attraction.

Katherine N Weilbaecher1, Theresa A Guise, Laurie K McCauley.   

Abstract

When cancer metastasizes to bone, considerable pain and deregulated bone remodelling occurs, greatly diminishing the possibility of cure. Metastasizing tumour cells mobilize and sculpt the bone microenvironment to enhance tumour growth and to promote bone invasion. Understanding the crucial components of the bone microenvironment that influence tumour localization, along with the tumour-derived factors that modulate cellular and protein matrix components of bone to favour tumour expansion and invasion, is central to the pathophysiology of bone metastases. Basic findings of tumour-bone interactions have uncovered numerous therapeutic opportunities that focus on the bone microenvironment to prevent and treat bone metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593787      PMCID: PMC3666847          DOI: 10.1038/nrc3055

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  210 in total

Review 1.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

2.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  Identification of the haematopoietic stem cell niche and control of the niche size.

Authors:  Jiwang Zhang; Chao Niu; Ling Ye; Haiyang Huang; Xi He; Wei-Gang Tong; Jason Ross; Jeff Haug; Teri Johnson; Jian Q Feng; Stephen Harris; Leanne M Wiedemann; Yuji Mishina; Linheng Li
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

4.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

5.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.

Authors:  Juan Juan Yin; Khalid S Mohammad; Sanna M Käkönen; Stephen Harris; J Ruth Wu-Wong; Jerry L Wessale; Robert J Padley; I Ross Garrett; John M Chirgwin; Theresa A Guise
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-26       Impact factor: 11.205

6.  Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.

Authors:  Yan-Xi Sun; Jingcheng Wang; Charles E Shelburne; Dennis E Lopatin; Arul M Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Russell S Taichman
Journal:  J Cell Biochem       Date:  2003-06-01       Impact factor: 4.429

7.  Platelet and osteoclast beta3 integrins are critical for bone metastasis.

Authors:  Suzanne J Bakewell; Patrick Nestor; Srinivasa Prasad; Michael H Tomasson; Nikki Dowland; Mukund Mehrotra; Robert Scarborough; James Kanter; Keith Abe; David Phillips; Katherine N Weilbaecher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

8.  Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity.

Authors:  Olivier Peyruchaud; Claire-Marie Serre; Roisin NicAmhlaoibh; Pierrick Fournier; Philippe Clezardin
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

Review 9.  New insights into the molecular mechanisms of action of bisphosphonates.

Authors:  Michael J Rogers
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.

Authors:  Gabriele Carlinfante; Daphne Vassiliou; Olle Svensson; Mikael Wendel; Dick Heinegård; Göran Andersson
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  481 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

2.  Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Authors:  Toru Hiraga; Akira Myoui; Nobuyuki Hashimoto; Akira Sasaki; Kenji Hata; Yoshihiro Morita; Hideki Yoshikawa; Clifford J Rosen; Gregory R Mundy; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

3.  New secrets behind bone metastasis.

Authors:  Xing Guo; Xiao-Fan Wang
Journal:  Cell Res       Date:  2012-06-26       Impact factor: 25.617

4.  Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.

Authors:  Eric Hesse; Saskia Schröder; Diana Brandt; Jenny Pamperin; Hiroaki Saito; Hanna Taipaleenmäki
Journal:  JCI Insight       Date:  2019-04-09

5.  Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.

Authors:  Hiroki Wakabayashi; Satoshi Wakisaka; Toru Hiraga; Kenji Hata; Riko Nishimura; Makoto Tominaga; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2017-05-17       Impact factor: 2.626

6.  A thermoresponsive, citrate-based macromolecule for bone regenerative engineering.

Authors:  Simona Morochnik; Yunxiao Zhu; Chongwen Duan; Michelle Cai; Russell R Reid; Tong-Chuan He; Jason Koh; Igal Szleifer; Guillermo A Ameer
Journal:  J Biomed Mater Res A       Date:  2018-02-19       Impact factor: 4.396

7.  Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.

Authors:  Toru Hiraga; Hiroaki Nakamura
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

8.  RANKL: A promising circulating marker for bone metastasis response.

Authors:  Toni Ibrahim; Marianna Ricci; Emanuela Scarpi; Alberto Bongiovanni; Rossana Ricci; Nada Riva; Chiara Liverani; Alessandro De Vita; Federico La Manna; Devil Oboldi; Patrizia Serra; Flavia Foca; Lorenzo Cecconetto; Dino Amadori; Laura Mercatali
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

9.  Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.

Authors:  J L Werbeck; N K Thudi; C K Martin; C Premanandan; L Yu; M C Ostrowksi; T J Rosol
Journal:  Vet Pathol       Date:  2013-10-03       Impact factor: 2.221

Review 10.  The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.